Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fidia Spa ( (IT:FDA) ) has shared an update.
Fidia S.p.A. has announced an Extraordinary Meeting on January 9, 2026, to discuss a financing operation involving the issuance of a convertible bond loan and warrants, aimed at raising up to 5 million euros. This move is intended to enhance the company’s capital structure and potentially impact its market positioning by involving Global Growth Holding Limited, with implications for shareholder voting rights and share capital adjustments.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.15 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A. operates in the financial sector, focusing on financing operations and capital management. The company is involved in issuing convertible bonds and managing share capital, with its shares traded on Euronext Milan.
Average Trading Volume: 723,868
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2.52M
Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.